Respiratory epithelial cells require Toll-like receptor 4 for induction of human beta-defensin 2 by lipopolysaccharide

The respiratory epithelium is a major portal of entry for pathogens and employs innate defense mechanisms to prevent colonization and infection. Induced expression of human beta-defensin 2 (HBD2) represents a direct response by the epithelium to potential infection. Here we provide evidence for the...

Full description

Saved in:
Bibliographic Details
Published inRespiratory research Vol. 6; no. 1; p. 116
Main Authors MacRedmond, Ruth, Greene, Catherine, Taggart, Clifford C, McElvaney, Noel, O'Neill, Shane
Format Journal Article
LanguageEnglish
Published England BioMed Central Ltd 12.10.2005
BioMed Central
BMC
Subjects
Online AccessGet full text

Cover

Loading…
Abstract The respiratory epithelium is a major portal of entry for pathogens and employs innate defense mechanisms to prevent colonization and infection. Induced expression of human beta-defensin 2 (HBD2) represents a direct response by the epithelium to potential infection. Here we provide evidence for the critical role of Toll-like receptor 4 (TLR4) in lipopolysaccharide (LPS)-induced HBD2 expression by human A549 epithelial cells. Using RTPCR, fluorescence microscopy, ELISA and luciferase reporter gene assays we quantified interleukin-8, TLR4 and HBD2 expression in unstimulated or agonist-treated A549 and/or HEK293 cells. We also assessed the effect of over expressing wild type and/or mutant TLR4, MyD88 and/or Mal transgenes on LPS-induced HBD2 expression in these cells. We demonstrate that A549 cells express TLR4 on their surface and respond directly to Pseudomonas LPS with increased HBD2 gene and protein expression. These effects are blocked by a TLR4 neutralizing antibody or functionally inactive TLR4, MyD88 and/or Mal transgenes. We further implicate TLR4 in LPS-induced HBD2 production by demonstrating HBD2 expression in LPS non-responsive HEK293 cells transfected with a TLR4 expression plasmid. This data defines an additional role for TLR4 in the host defense in the lung.
AbstractList Abstract Background The respiratory epithelium is a major portal of entry for pathogens and employs innate defense mechanisms to prevent colonization and infection. Induced expression of human β-defensin 2 (HBD2) represents a direct response by the epithelium to potential infection. Here we provide evidence for the critical role of Toll-like receptor 4 (TLR4) in lipopolysaccharide (LPS)-induced HBD2 expression by human A549 epithelial cells. Methods Using RTPCR, fluorescence microscopy, ELISA and luciferase reporter gene assays we quantified interleukin-8, TLR4 and HBD2 expression in unstimulated or agonist-treated A549 and/or HEK293 cells. We also assessed the effect of over expressing wild type and/or mutant TLR4, MyD88 and/or Mal transgenes on LPS-induced HBD2 expression in these cells. Results We demonstrate that A549 cells express TLR4 on their surface and respond directly to Pseudomonas LPS with increased HBD2 gene and protein expression. These effects are blocked by a TLR4 neutralizing antibody or functionally inactive TLR4, MyD88 and/or Mal transgenes. We further implicate TLR4 in LPS-induced HBD2 production by demonstrating HBD2 expression in LPS non-responsive HEK293 cells transfected with a TLR4 expression plasmid. Conclusion This data defines an additional role for TLR4 in the host defense in the lung.
Abstract Background The respiratory epithelium is a major portal of entry for pathogens and employs innate defense mechanisms to prevent colonization and infection. Induced expression of human β-defensin 2 (HBD2) represents a direct response by the epithelium to potential infection. Here we provide evidence for the critical role of Toll-like receptor 4 (TLR4) in lipopolysaccharide (LPS)-induced HBD2 expression by human A549 epithelial cells. Methods Using RTPCR, fluorescence microscopy, ELISA and luciferase reporter gene assays we quantified interleukin-8, TLR4 and HBD2 expression in unstimulated or agonist-treated A549 and/or HEK293 cells. We also assessed the effect of over expressing wild type and/or mutant TLR4, MyD88 and/or Mal transgenes on LPS-induced HBD2 expression in these cells. Results We demonstrate that A549 cells express TLR4 on their surface and respond directly to Pseudomonas LPS with increased HBD2 gene and protein expression. These effects are blocked by a TLR4 neutralizing antibody or functionally inactive TLR4, MyD88 and/or Mal transgenes. We further implicate TLR4 in LPS-induced HBD2 production by demonstrating HBD2 expression in LPS non-responsive HEK293 cells transfected with a TLR4 expression plasmid. Conclusion This data defines an additional role for TLR4 in the host defense in the lung.
The respiratory epithelium is a major portal of entry for pathogens and employs innate defense mechanisms to prevent colonization and infection. Induced expression of human beta -defensin 2 (HBD2) represents a direct response by the epithelium to potential infection. Here we provide evidence for the critical role of Toll-like receptor 4 (TLR4) in lipopolysaccharide (LPS)-induced HBD2 expression by human A549 epithelial cells. Methods Using RTPCR, fluorescence microscopy, ELISA and luciferase reporter gene assays we quantified interleukin- 8, TLR4 and HBD2 expression in unstimulated or agonist-treated A549 and/or HEK293 cells. We also assessed the effect of over expressing wild type and/or mutant TLR4, MyD88 and/or Mal transgenes on LPS-induced HBD2 expression in these cells. Results We demonstrate that A549 cells express TLR4 on their surface and respond directly to Pseudomonas LPS with increased HBD2 gene and protein expression. These effects are blocked by a TLR4 neutralizing antibody or functionally inactive TLR4, MyD88 and/or Mal transgenes. We further implicate TLR4 in LPS-induced HBD2 production by demonstrating HBD2 expression in LPS non- responsive HEK293 cells transfected with a TLR4 expression plasmid. Conclusion This data defines an additional role for TLR4 in the host defense in the lung.
BACKGROUND: The respiratory epithelium is a major portal of entry for pathogens and employs innate defense mechanisms to prevent colonization and infection. Induced expression of human β-defensin 2 (HBD2) represents a direct response by the epithelium to potential infection. Here we provide evidence for the critical role of Toll-like receptor 4 (TLR4) in lipopolysaccharide (LPS)-induced HBD2 expression by human A549 epithelial cells. METHODS: Using RTPCR, fluorescence microscopy, ELISA and luciferase reporter gene assays we quantified interleukin-8, TLR4 and HBD2 expression in unstimulated or agonist-treated A549 and/or HEK293 cells. We also assessed the effect of over expressing wild type and/or mutant TLR4, MyD88 and/or Mal transgenes on LPS-induced HBD2 expression in these cells. RESULTS: We demonstrate that A549 cells express TLR4 on their surface and respond directly to Pseudomonas LPS with increased HBD2 gene and protein expression. These effects are blocked by a TLR4 neutralizing antibody or functionally inactive TLR4, MyD88 and/or Mal transgenes. We further implicate TLR4 in LPS-induced HBD2 production by demonstrating HBD2 expression in LPS non-responsive HEK293 cells transfected with a TLR4 expression plasmid. CONCLUSION: This data defines an additional role for TLR4 in the host defense in the lung.
BACKGROUNDThe respiratory epithelium is a major portal of entry for pathogens and employs innate defense mechanisms to prevent colonization and infection. Induced expression of human beta-defensin 2 (HBD2) represents a direct response by the epithelium to potential infection. Here we provide evidence for the critical role of Toll-like receptor 4 (TLR4) in lipopolysaccharide (LPS)-induced HBD2 expression by human A549 epithelial cells.METHODSUsing RTPCR, fluorescence microscopy, ELISA and luciferase reporter gene assays we quantified interleukin-8, TLR4 and HBD2 expression in unstimulated or agonist-treated A549 and/or HEK293 cells. We also assessed the effect of over expressing wild type and/or mutant TLR4, MyD88 and/or Mal transgenes on LPS-induced HBD2 expression in these cells.RESULTSWe demonstrate that A549 cells express TLR4 on their surface and respond directly to Pseudomonas LPS with increased HBD2 gene and protein expression. These effects are blocked by a TLR4 neutralizing antibody or functionally inactive TLR4, MyD88 and/or Mal transgenes. We further implicate TLR4 in LPS-induced HBD2 production by demonstrating HBD2 expression in LPS non-responsive HEK293 cells transfected with a TLR4 expression plasmid.CONCLUSIONThis data defines an additional role for TLR4 in the host defense in the lung.
The respiratory epithelium is a major portal of entry for pathogens and employs innate defense mechanisms to prevent colonization and infection. Induced expression of human beta-defensin 2 (HBD2) represents a direct response by the epithelium to potential infection. Here we provide evidence for the critical role of Toll-like receptor 4 (TLR4) in lipopolysaccharide (LPS)-induced HBD2 expression by human A549 epithelial cells. Using RTPCR, fluorescence microscopy, ELISA and luciferase reporter gene assays we quantified interleukin-8, TLR4 and HBD2 expression in unstimulated or agonist-treated A549 and/or HEK293 cells. We also assessed the effect of over expressing wild type and/or mutant TLR4, MyD88 and/or Mal transgenes on LPS-induced HBD2 expression in these cells. We demonstrate that A549 cells express TLR4 on their surface and respond directly to Pseudomonas LPS with increased HBD2 gene and protein expression. These effects are blocked by a TLR4 neutralizing antibody or functionally inactive TLR4, MyD88 and/or Mal transgenes. We further implicate TLR4 in LPS-induced HBD2 production by demonstrating HBD2 expression in LPS non-responsive HEK293 cells transfected with a TLR4 expression plasmid. This data defines an additional role for TLR4 in the host defense in the lung.
ArticleNumber 116
Author MacRedmond, Ruth
O'Neill, Shane
Taggart, Clifford C
McElvaney, Noel
Greene, Catherine
AuthorAffiliation 1 Department of Respiratory Research, Royal College of Surgeons in Ireland, Beaumont Hospital, Dublin 9, Ireland
AuthorAffiliation_xml – name: 1 Department of Respiratory Research, Royal College of Surgeons in Ireland, Beaumont Hospital, Dublin 9, Ireland
Author_xml – sequence: 1
  givenname: Ruth
  surname: MacRedmond
  fullname: MacRedmond, Ruth
  email: rmacredm@vch.ca
  organization: Department of Respiratory Research, Royal College of Surgeons in Ireland, Beaumont Hospital, Dublin 9, Ireland. rmacredm@vch.ca
– sequence: 2
  givenname: Catherine
  surname: Greene
  fullname: Greene, Catherine
– sequence: 3
  givenname: Clifford C
  surname: Taggart
  fullname: Taggart, Clifford C
– sequence: 4
  givenname: Noel
  surname: McElvaney
  fullname: McElvaney, Noel
– sequence: 5
  givenname: Shane
  surname: O'Neill
  fullname: O'Neill, Shane
BackLink https://www.ncbi.nlm.nih.gov/pubmed/16219107$$D View this record in MEDLINE/PubMed
BookMark eNp9ks9rFDEUx4NU7A89e5OcvI2dZDKZyUXQUrVQEKSCt_CSedNNzSbTZKaw_73Z7qJdUC9J-L4vH97L952SoxADEvKa1e8Y6-U5E7KtlOKskhVj8hk52SvNj6Mn72NymvNdXbOu79oX5JhJzhSruxPy8A3z5BLMMW0oTm5eoXfgqUXvM014v7iE9CZ6X3n3E4ticSpmKuhYTheGxc4uBhpHulrWEKjBGaoBRwzZBcqp2VDvpjhFv8lg7QqSG_AleT6Cz_hqf5-R758uby6-VNdfP19dfLiujJBcVoDQKtXXdWtMPTAAg8rypmbDWAQzDqoBHKFFaRXKvhUGuRKNAN4YaFnbnJGrHXeIcKen5NaQNjqC049CTLca0uysR81qiQ0fLAcUAnmhdr2S2Fsm5ThaVVjvd6xpMWscLIY5gT-AHlaCW-nb-KAZ72TPugL4uAMYF_8BOKzYuNbbDPU2YS11SbhA3u67SPF-wTzrtcvbtCBgXLKWJeG-eRz9_0ameiG6VhTj-c5oU8w54fi7I1br7Zb9pYc3T3_ij3-_Vs0v9tvTPw
CitedBy_id crossref_primary_10_1111_j_1464_410X_2010_09469_x
crossref_primary_10_1016_j_critrevonc_2013_08_010
crossref_primary_10_1074_jbc_M112_362178
crossref_primary_10_3390_cells10112991
crossref_primary_10_1152_ajpgi_00582_2006
crossref_primary_10_1186_s12944_016_0294_4
crossref_primary_10_1039_D1FO00269D
crossref_primary_10_3390_ijms21031148
crossref_primary_10_1007_s00405_016_4270_4
crossref_primary_10_1095_biolreprod_106_053967
crossref_primary_10_1007_s10753_014_0083_z
crossref_primary_10_1016_j_intimp_2018_11_014
crossref_primary_10_1080_01902140802130105
crossref_primary_10_3892_mmr_2017_8108
crossref_primary_10_1016_j_peptides_2007_09_009
crossref_primary_10_33549_physiolres_933672
crossref_primary_10_1371_journal_pone_0203621
crossref_primary_10_1159_000439226
crossref_primary_10_1371_journal_pone_0021827
crossref_primary_10_1111_j_1462_5822_2009_01421_x
crossref_primary_10_1165_rcmb_2011_0011RT
crossref_primary_10_1155_2010_423241
crossref_primary_10_1038_onc_2009_289
crossref_primary_10_1182_blood_2008_07_166934
crossref_primary_10_1186_1465_9921_7_29
crossref_primary_10_1002_ijc_29111
crossref_primary_10_1111_jre_12641
crossref_primary_10_1007_s12275_013_2579_x
crossref_primary_10_1111_j_1365_2133_2007_07899_x
crossref_primary_10_1371_journal_ppat_1000405
crossref_primary_10_3390_clinpract13010012
crossref_primary_10_1111_bju_12196
crossref_primary_10_1152_ajplung_00536_2007
crossref_primary_10_1007_s10585_020_10018_2
crossref_primary_10_1016_j_canlet_2009_01_010
crossref_primary_10_1111_imm_12352
crossref_primary_10_1007_s10989_015_9469_5
crossref_primary_10_3390_ijerph13040359
crossref_primary_10_1016_j_bbrc_2008_04_092
crossref_primary_10_1016_j_cbi_2021_109729
crossref_primary_10_1093_toxsci_kfr310
crossref_primary_10_3390_pharmaceutics11010012
crossref_primary_10_1186_1465_9921_8_84
crossref_primary_10_3389_fviro_2022_908704
crossref_primary_10_1194_jlr_M000513
crossref_primary_10_1016_j_intimp_2024_112066
crossref_primary_10_1038_s41598_024_66568_y
crossref_primary_10_3168_jds_2019_16332
crossref_primary_10_1097_MBC_0b013e328346ef56
crossref_primary_10_1183_13993003_02222_2019
crossref_primary_10_3760_cma_j_issn_0366_6999_2010_13_027
crossref_primary_10_1111_cmi_12522
crossref_primary_10_1152_ajplung_00137_2007
crossref_primary_10_1155_2021_8874339
crossref_primary_10_1016_j_joen_2006_01_010
crossref_primary_10_1016_j_intimp_2009_07_008
crossref_primary_10_1007_s00232_014_9675_7
crossref_primary_10_1016_j_jep_2010_12_006
crossref_primary_10_1128_IAI_00056_06
crossref_primary_10_1007_s00011_010_0208_2
crossref_primary_10_1371_journal_pone_0033601
crossref_primary_10_18093_0869_0189_2010_5_101_109
crossref_primary_10_1002_cbin_10755
crossref_primary_10_1016_j_toxlet_2016_06_2105
crossref_primary_10_1128_IAI_01980_06
crossref_primary_10_2337_db08_0038
crossref_primary_10_1095_biolreprod_108_069930
crossref_primary_10_1080_15287391003614042
crossref_primary_10_1016_j_peptides_2008_05_019
crossref_primary_10_1152_ajplung_00215_2014
crossref_primary_10_1128_CVI_00296_06
crossref_primary_10_1128_AAC_06062_11
crossref_primary_10_4103_MJBL_MJBL_308_22
crossref_primary_10_14777_uti_2015_10_2_57
crossref_primary_10_1177_1753425911426591
Cites_doi 10.1016/S0014-5793(03)00482-4
10.1074/jbc.M305790200
10.1074/jbc.M308093200
10.1016/S0954-6111(98)90191-3
10.1172/JCI6709
10.1046/j.1365-3083.2002.01137.x
10.4049/jimmunol.141.2.547
10.1165/ajrcmb.22.6.4023
10.4049/jimmunol.172.1.608
10.1126/science.286.5439.525
10.1074/jbc.M105228200
10.4049/jimmunol.169.9.4697
10.4049/jimmunol.173.9.5398
10.1016/S0167-5699(97)01197-3
10.1111/j.1432-1033.1991.tb16069.x
10.1086/345799
10.1016/S0014-5793(03)00577-5
10.1189/jlb.71.1.154
10.1152/ajplung.00377.2003
10.1111/j.1574-6968.2002.tb10979.x
10.4049/jimmunol.171.10.5272
10.1016/j.smim.2003.10.003
10.1152/ajplung.2000.278.4.L658
10.1378/chest.115.3.829
10.4049/jimmunol.165.12.6682
10.1128/CMR.14.2.336-363.2001
10.1016/j.molimm.2003.10.006
10.1074/jbc.M000184200
10.1073/pnas.95.25.14961
10.1128/IAI.67.9.4744-4750.1999
10.1073/pnas.042692699
10.1007/s004080000031
10.1038/nrmicro818
10.4049/jimmunol.158.8.3925
10.1177/09680519030090010701
10.1073/pnas.93.10.5156
10.4049/jimmunol.171.12.6820
10.1172/JCI0215218
10.1183/09031936.03.00098803
10.1038/nri1180
10.1016/S1286-4579(02)01604-0
10.1016/S1286-4579(00)01259-4
10.1002/jlb.67.4.508
10.4049/jimmunol.170.8.4226
10.1093/oxfordjournals.epirev.a036050
ContentType Journal Article
Copyright Copyright © 2005 MacRedmond et al; licensee BioMed Central Ltd. 2005 MacRedmond et al; licensee BioMed Central Ltd.
Copyright_xml – notice: Copyright © 2005 MacRedmond et al; licensee BioMed Central Ltd. 2005 MacRedmond et al; licensee BioMed Central Ltd.
DBID CGR
CUY
CVF
ECM
EIF
NPM
AAYXX
CITATION
7QL
7T5
C1K
H94
7X8
5PM
DOA
DOI 10.1186/1465-9921-6-116
DatabaseName Medline
MEDLINE
MEDLINE (Ovid)
MEDLINE
MEDLINE
PubMed
CrossRef
Bacteriology Abstracts (Microbiology B)
Immunology Abstracts
Environmental Sciences and Pollution Management
AIDS and Cancer Research Abstracts
MEDLINE - Academic
PubMed Central (Full Participant titles)
DOAJ Directory of Open Access Journals
DatabaseTitle MEDLINE
Medline Complete
MEDLINE with Full Text
PubMed
MEDLINE (Ovid)
CrossRef
AIDS and Cancer Research Abstracts
Immunology Abstracts
Bacteriology Abstracts (Microbiology B)
Environmental Sciences and Pollution Management
MEDLINE - Academic
DatabaseTitleList CrossRef

AIDS and Cancer Research Abstracts

MEDLINE - Academic
MEDLINE
Database_xml – sequence: 1
  dbid: DOA
  name: Directory of Open Access Journals
  url: https://www.doaj.org/
  sourceTypes: Open Website
– sequence: 2
  dbid: NPM
  name: PubMed
  url: https://proxy.k.utb.cz/login?url=http://www.ncbi.nlm.nih.gov/entrez/query.fcgi?db=PubMed
  sourceTypes: Index Database
– sequence: 3
  dbid: EIF
  name: MEDLINE
  url: https://proxy.k.utb.cz/login?url=https://www.webofscience.com/wos/medline/basic-search
  sourceTypes: Index Database
DeliveryMethod fulltext_linktorsrc
Discipline Medicine
EISSN 1465-993X
1465-9921
EndPage 116
ExternalDocumentID oai_doaj_org_article_106e32dc2ae44e2fa57896e8c166ffc9
oai_biomedcentral_com_1465_9921_6_116
10_1186_1465_9921_6_116
16219107
Genre Research Support, Non-U.S. Gov't
Journal Article
GroupedDBID ---
-A0
0R~
29P
2VQ
2WC
4.4
53G
5VS
AAFWJ
AAJSJ
AAWTL
ABDBF
ACGFO
ACGFS
ACIHN
ACPRK
ACRMQ
ADBBV
ADINQ
ADRAZ
ADUKV
AEAQA
AENEX
AFRAH
AHBYD
AHMBA
AHSBF
AHYZX
ALIPV
ALMA_UNASSIGNED_HOLDINGS
AMKLP
AMTXH
AOIJS
BAPOH
BAWUL
BCNDV
BFQNJ
BMC
C24
C6C
CGR
CS3
CUY
CVF
DIK
DU5
E3Z
EAD
EAP
EAS
EBD
EBLON
EBS
ECM
EIF
EJD
EMB
EMK
EMOBN
ESX
F5P
FRP
GROUPED_DOAJ
GX1
HYE
IAO
IHR
INH
INR
IPNFZ
ITC
KQ8
M48
M~E
NPM
O5R
O5S
OK1
P2P
PGMZT
RBZ
RIG
RNS
ROL
RPM
RSV
SMD
SOJ
SV3
TR2
TUS
W2D
WOQ
WOW
XSB
AAYXX
AFPKN
CITATION
7QL
7T5
AFGXO
C1K
H94
7X8
ABVAZ
AFNRJ
5PM
ID FETCH-LOGICAL-b4626-aea5998005bb0d1aabe9c2301dfbb0bfd93aefa5e6c9e6854be29434a23ba5153
IEDL.DBID RBZ
ISSN 1465-993X
1465-9921
IngestDate Fri Oct 04 12:52:33 EDT 2024
Tue Sep 17 20:40:14 EDT 2024
Wed May 22 07:13:25 EDT 2024
Sat Aug 17 02:58:54 EDT 2024
Fri Aug 16 22:26:45 EDT 2024
Thu Sep 12 18:13:56 EDT 2024
Tue Oct 15 23:29:17 EDT 2024
IsDoiOpenAccess true
IsOpenAccess true
IsPeerReviewed true
IsScholarly true
Issue 1
Language English
License This is an Open Access article distributed under the terms of the Creative Commons Attribution License (), which permits unrestricted use, distribution, and reproduction in any medium, provided the original work is properly cited.
LinkModel DirectLink
MergedId FETCHMERGED-LOGICAL-b4626-aea5998005bb0d1aabe9c2301dfbb0bfd93aefa5e6c9e6854be29434a23ba5153
Notes ObjectType-Article-1
SourceType-Scholarly Journals-1
ObjectType-Feature-2
content type line 23
OpenAccessLink http://dx.doi.org/10.1186/1465-9921-6-116
PMID 16219107
PQID 19844754
PQPubID 23462
PageCount 1
ParticipantIDs doaj_primary_oai_doaj_org_article_106e32dc2ae44e2fa57896e8c166ffc9
pubmedcentral_primary_oai_pubmedcentral_nih_gov_1276817
biomedcentral_primary_oai_biomedcentral_com_1465_9921_6_116
proquest_miscellaneous_68758315
proquest_miscellaneous_19844754
crossref_primary_10_1186_1465_9921_6_116
pubmed_primary_16219107
PublicationCentury 2000
PublicationDate 2005-10-12
PublicationDateYYYYMMDD 2005-10-12
PublicationDate_xml – month: 10
  year: 2005
  text: 2005-10-12
  day: 12
PublicationDecade 2000
PublicationPlace England
PublicationPlace_xml – name: England
– name: London
PublicationTitle Respiratory research
PublicationTitleAlternate Respir Res
PublicationYear 2005
Publisher BioMed Central Ltd
BioMed Central
BMC
Publisher_xml – name: BioMed Central Ltd
– name: BioMed Central
– name: BMC
References 9227502 - Am J Physiol. 1997 Jun;272(6 Pt 1):L1046-52
10882713 - J Biol Chem. 2000 Sep 22;275(38):29731-6
14688373 - J Immunol. 2004 Jan 1;172(1):608-16
14656745 - Am J Respir Cell Mol Biol. 2004 Jun;30(6):777-83
3385210 - J Immunol. 1988 Jul 15;141(2):547-52
12691620 - J Endotoxin Res. 2003;9(1):55-9
10521347 - Science. 1999 Oct 15;286(5439):525-8
11901174 - J Clin Invest. 2002 Mar;109(6):693-7
12782302 - FEBS Lett. 2003 Jun 5;544(1-3):129-32
11120784 - J Immunol. 2000 Dec 15;165(12):6682-6
14698224 - Mol Immunol. 2004 Feb;40(12):861-8
11777841 - Clin Diagn Lab Immunol. 2002 Jan;9(1):126-31
15121639 - Am J Physiol Lung Cell Mol Physiol. 2004 Aug;287(2):L428-37
11500507 - J Biol Chem. 2001 Oct 12;276(41):38044-51
12193231 - Scand J Immunol. 2002 Sep;56(3):294-302
10837369 - Am J Respir Cell Mol Biol. 2000 Jun;22(6):714-21
1904818 - Eur J Biochem. 1991 Jun 15;198(3):697-704
9103463 - J Immunol. 1997 Apr 15;158(8):3925-34
10749742 - Am J Physiol Lung Cell Mol Physiol. 2000 Apr;278(4):L658-66
12682256 - J Immunol. 2003 Apr 15;170(8):4226-36
8643545 - Proc Natl Acad Sci U S A. 1996 May 14;93(10):5156-60
14751757 - Semin Immunol. 2004 Feb;16(1):3-9
14600154 - J Biol Chem. 2004 Jan 23;279(4):2712-8
12832046 - FEBS Lett. 2003 Jul 10;546(2-3):233-6
9509763 - Immunol Today. 1998 Feb;19(2):80-8
10070565 - Respir Med. 1998 Jul;92(7):922-7
15494486 - J Immunol. 2004 Nov 1;173(9):5398-405
11147311 - Lung. 2000;178(5):261-9
12270731 - Microbes Infect. 2002 Jul;4(8):837-51
14565959 - J Biol Chem. 2003 Dec 26;278(52):53035-44
10967285 - Microbes Infect. 2000 Jul;2(9):1051-60
2286216 - Epidemiol Rev. 1990;12:149-78
9843998 - Proc Natl Acad Sci U S A. 1998 Dec 8;95(25):14961-6
12391175 - J Immunol. 2002 Nov 1;169(9):4697-701
14662888 - J Immunol. 2003 Dec 15;171(12):6820-6
10430608 - J Clin Invest. 1999 Aug;104(3):271-80
11854508 - Proc Natl Acad Sci U S A. 2002 Feb 19;99(4):2129-33
14607928 - J Immunol. 2003 Nov 15;171(10):5272-6
14979512 - Eur Respir J. 2004 Feb;23(2):327-33
12447765 - J Infect Dis. 2002 Dec 15;186(12):1790-6
10770283 - J Leukoc Biol. 2000 Apr;67(4):508-14
11786250 - FEMS Microbiol Lett. 2002 Jan 2;206(1):9-18
10084499 - Chest. 1999 Mar;115(3):829-35
11292642 - Clin Microbiol Rev. 2001 Apr;14(2):336-63
12949495 - Nat Rev Immunol. 2003 Sep;3(9):710-20
15040260 - Nat Rev Microbiol. 2004 Feb;2(2):123-40
10456926 - Infect Immun. 1999 Sep;67(9):4744-50
11781391 - J Leukoc Biol. 2002 Jan;71(1):154-62
T Ganz (354_CR7_354) 2003; 3
S Griffin (354_CR20_354) 2003; 546
A Bowie (354_CR1_354) 2000; 67
MM Wurfel (354_CR35_354) 1997; 158
L Guillot (354_CR23_354) 2004; 279
C Erridge (354_CR31_354) 2002; 4
S Sethi (354_CR13_354) 2001; 14
LA O'Neill (354_CR42_354) 2003; 9
K Takeda (354_CR43_354) 2004; 16
MM Monick (354_CR17_354) 2003; 278
PA Raj (354_CR8_354) 2002; 206
T Ganz (354_CR5_354) 2002; 109
P Vora (354_CR15_354) 2004; 173
MJ May (354_CR2_354) 1998; 19
F Re (354_CR22_354) 2003; 171
KI Iwami (354_CR48_354) 2000; 165
A Muir (354_CR37_354) 2003
RB Parad (354_CR14_354) 1999; 67
JB Kaper (354_CR29_354) 2004; 2
HP Jia (354_CR18_354) 2004; 287
JB Lyczak (354_CR33_354) 2000; 2
BC Schutte (354_CR9_354) 2002; 99
MN Becker (354_CR16_354) 2000; 275
VA Kulshin (354_CR32_354) 1991; 198
S Viriyakosol (354_CR36_354) 2001; 276
G Diamond (354_CR39_354) 1996; 93
NM Graham (354_CR44_354) 1990; 12
CJ Hertz (354_CR12_354) 2003; 171
A Haziot (354_CR40_354) 1988; 141
PK Singh (354_CR11_354) 1998; 95
M Yamamoto (354_CR3_354) 2004; 40
JM Devaney (354_CR24_354) 2003; 544
S Frantz (354_CR21_354) 1999; 104
S Koyama (354_CR34_354) 2000; 278
N Keicho (354_CR27_354) 1997; 272
C Schulz (354_CR30_354) 2002; 56
Y Tsutsumi-Ishii (354_CR26_354) 2003; 170
D Yang (354_CR4_354) 1999; 286
JD Hasday (354_CR47_354) 1999; 115
T Krakauer (354_CR28_354) 2002; 9
AO Azghani (354_CR38_354) 2000; 178
T Ohta (354_CR46_354) 1998; 92
J Harder (354_CR10_354) 2000; 22
C Greene (354_CR19_354) 2002; 186
JH Lee (354_CR25_354) 2004; 172
R Bals (354_CR6_354) 2004; 23
M Renshaw (354_CR45_354) 2002; 169
Y Tsutsumi-Ishii (354_CR41_354) 2002; 71
References_xml – volume: 544
  start-page: 129
  year: 2003
  ident: 354_CR24_354
  publication-title: FEBS Lett
  doi: 10.1016/S0014-5793(03)00482-4
  contributor:
    fullname: JM Devaney
– volume: 279
  start-page: 2712
  year: 2004
  ident: 354_CR23_354
  publication-title: J Biol Chem
  doi: 10.1074/jbc.M305790200
  contributor:
    fullname: L Guillot
– volume: 278
  start-page: 53035
  year: 2003
  ident: 354_CR17_354
  publication-title: J Biol Chem
  doi: 10.1074/jbc.M308093200
  contributor:
    fullname: MM Monick
– volume: 92
  start-page: 922
  year: 1998
  ident: 354_CR46_354
  publication-title: Respir Med
  doi: 10.1016/S0954-6111(98)90191-3
  contributor:
    fullname: T Ohta
– volume: 104
  start-page: 271
  year: 1999
  ident: 354_CR21_354
  publication-title: J Clin Invest
  doi: 10.1172/JCI6709
  contributor:
    fullname: S Frantz
– volume: 56
  start-page: 294
  year: 2002
  ident: 354_CR30_354
  publication-title: Scand J Immunol
  doi: 10.1046/j.1365-3083.2002.01137.x
  contributor:
    fullname: C Schulz
– volume: 141
  start-page: 547
  year: 1988
  ident: 354_CR40_354
  publication-title: J Immunol
  doi: 10.4049/jimmunol.141.2.547
  contributor:
    fullname: A Haziot
– volume: 22
  start-page: 714
  year: 2000
  ident: 354_CR10_354
  publication-title: Am J Respir Cell Mol Biol
  doi: 10.1165/ajrcmb.22.6.4023
  contributor:
    fullname: J Harder
– volume: 172
  start-page: 608
  year: 2004
  ident: 354_CR25_354
  publication-title: J Immunol
  doi: 10.4049/jimmunol.172.1.608
  contributor:
    fullname: JH Lee
– volume: 286
  start-page: 525
  year: 1999
  ident: 354_CR4_354
  publication-title: Science
  doi: 10.1126/science.286.5439.525
  contributor:
    fullname: D Yang
– volume: 276
  start-page: 38044
  year: 2001
  ident: 354_CR36_354
  publication-title: J Biol Chem
  doi: 10.1074/jbc.M105228200
  contributor:
    fullname: S Viriyakosol
– volume: 169
  start-page: 4697
  year: 2002
  ident: 354_CR45_354
  publication-title: J Immunol
  doi: 10.4049/jimmunol.169.9.4697
  contributor:
    fullname: M Renshaw
– volume-title: Am J Respir Cell Mol Biol
  year: 2003
  ident: 354_CR37_354
  contributor:
    fullname: A Muir
– volume: 173
  start-page: 5398
  year: 2004
  ident: 354_CR15_354
  publication-title: J Immunol
  doi: 10.4049/jimmunol.173.9.5398
  contributor:
    fullname: P Vora
– volume: 19
  start-page: 80
  year: 1998
  ident: 354_CR2_354
  publication-title: Immunol Today
  doi: 10.1016/S0167-5699(97)01197-3
  contributor:
    fullname: MJ May
– volume: 198
  start-page: 697
  year: 1991
  ident: 354_CR32_354
  publication-title: Eur J Biochem
  doi: 10.1111/j.1432-1033.1991.tb16069.x
  contributor:
    fullname: VA Kulshin
– volume: 186
  start-page: 1790
  year: 2002
  ident: 354_CR19_354
  publication-title: J Infect Dis
  doi: 10.1086/345799
  contributor:
    fullname: C Greene
– volume: 546
  start-page: 233
  year: 2003
  ident: 354_CR20_354
  publication-title: FEBS Lett
  doi: 10.1016/S0014-5793(03)00577-5
  contributor:
    fullname: S Griffin
– volume: 272
  start-page: L1046
  year: 1997
  ident: 354_CR27_354
  publication-title: Am J Physiol
  contributor:
    fullname: N Keicho
– volume: 71
  start-page: 154
  year: 2002
  ident: 354_CR41_354
  publication-title: J Leukoc Biol
  doi: 10.1189/jlb.71.1.154
  contributor:
    fullname: Y Tsutsumi-Ishii
– volume: 287
  start-page: L428
  year: 2004
  ident: 354_CR18_354
  publication-title: Am J Physiol Lung Cell Mol Physiol
  doi: 10.1152/ajplung.00377.2003
  contributor:
    fullname: HP Jia
– volume: 206
  start-page: 9
  year: 2002
  ident: 354_CR8_354
  publication-title: FEMS Microbiol Lett
  doi: 10.1111/j.1574-6968.2002.tb10979.x
  contributor:
    fullname: PA Raj
– volume: 171
  start-page: 5272
  year: 2003
  ident: 354_CR22_354
  publication-title: J Immunol
  doi: 10.4049/jimmunol.171.10.5272
  contributor:
    fullname: F Re
– volume: 16
  start-page: 3
  year: 2004
  ident: 354_CR43_354
  publication-title: Semin Immunol
  doi: 10.1016/j.smim.2003.10.003
  contributor:
    fullname: K Takeda
– volume: 278
  start-page: L658
  year: 2000
  ident: 354_CR34_354
  publication-title: Am J Physiol Lung Cell Mol Physiol
  doi: 10.1152/ajplung.2000.278.4.L658
  contributor:
    fullname: S Koyama
– volume: 115
  start-page: 829
  year: 1999
  ident: 354_CR47_354
  publication-title: Chest
  doi: 10.1378/chest.115.3.829
  contributor:
    fullname: JD Hasday
– volume: 165
  start-page: 6682
  year: 2000
  ident: 354_CR48_354
  publication-title: J Immunol
  doi: 10.4049/jimmunol.165.12.6682
  contributor:
    fullname: KI Iwami
– volume: 14
  start-page: 336
  year: 2001
  ident: 354_CR13_354
  publication-title: Clin Microbiol Rev
  doi: 10.1128/CMR.14.2.336-363.2001
  contributor:
    fullname: S Sethi
– volume: 40
  start-page: 861
  year: 2004
  ident: 354_CR3_354
  publication-title: Mol Immunol
  doi: 10.1016/j.molimm.2003.10.006
  contributor:
    fullname: M Yamamoto
– volume: 275
  start-page: 29731
  year: 2000
  ident: 354_CR16_354
  publication-title: J Biol Chem
  doi: 10.1074/jbc.M000184200
  contributor:
    fullname: MN Becker
– volume: 95
  start-page: 14961
  year: 1998
  ident: 354_CR11_354
  publication-title: Proc Natl Acad Sci U S A
  doi: 10.1073/pnas.95.25.14961
  contributor:
    fullname: PK Singh
– volume: 67
  start-page: 4744
  year: 1999
  ident: 354_CR14_354
  publication-title: Infect Immun
  doi: 10.1128/IAI.67.9.4744-4750.1999
  contributor:
    fullname: RB Parad
– volume: 9
  start-page: 126
  year: 2002
  ident: 354_CR28_354
  publication-title: Clin Diagn Lab Immunol
  contributor:
    fullname: T Krakauer
– volume: 99
  start-page: 2129
  year: 2002
  ident: 354_CR9_354
  publication-title: Proc Natl Acad Sci U S A
  doi: 10.1073/pnas.042692699
  contributor:
    fullname: BC Schutte
– volume: 178
  start-page: 261
  year: 2000
  ident: 354_CR38_354
  publication-title: Lung
  doi: 10.1007/s004080000031
  contributor:
    fullname: AO Azghani
– volume: 2
  start-page: 123
  year: 2004
  ident: 354_CR29_354
  publication-title: Nat Rev Microbiol
  doi: 10.1038/nrmicro818
  contributor:
    fullname: JB Kaper
– volume: 158
  start-page: 3925
  year: 1997
  ident: 354_CR35_354
  publication-title: J Immunol
  doi: 10.4049/jimmunol.158.8.3925
  contributor:
    fullname: MM Wurfel
– volume: 9
  start-page: 55
  year: 2003
  ident: 354_CR42_354
  publication-title: J Endotoxin Res
  doi: 10.1177/09680519030090010701
  contributor:
    fullname: LA O'Neill
– volume: 93
  start-page: 5156
  year: 1996
  ident: 354_CR39_354
  publication-title: Proc Natl Acad Sci U S A
  doi: 10.1073/pnas.93.10.5156
  contributor:
    fullname: G Diamond
– volume: 171
  start-page: 6820
  year: 2003
  ident: 354_CR12_354
  publication-title: J Immunol
  doi: 10.4049/jimmunol.171.12.6820
  contributor:
    fullname: CJ Hertz
– volume: 109
  start-page: 693
  year: 2002
  ident: 354_CR5_354
  publication-title: J Clin Invest
  doi: 10.1172/JCI0215218
  contributor:
    fullname: T Ganz
– volume: 23
  start-page: 327
  year: 2004
  ident: 354_CR6_354
  publication-title: Eur Respir J
  doi: 10.1183/09031936.03.00098803
  contributor:
    fullname: R Bals
– volume: 3
  start-page: 710
  year: 2003
  ident: 354_CR7_354
  publication-title: Nat Rev Immunol
  doi: 10.1038/nri1180
  contributor:
    fullname: T Ganz
– volume: 4
  start-page: 837
  year: 2002
  ident: 354_CR31_354
  publication-title: Microbes Infect
  doi: 10.1016/S1286-4579(02)01604-0
  contributor:
    fullname: C Erridge
– volume: 2
  start-page: 1051
  year: 2000
  ident: 354_CR33_354
  publication-title: Microbes Infect
  doi: 10.1016/S1286-4579(00)01259-4
  contributor:
    fullname: JB Lyczak
– volume: 67
  start-page: 508
  year: 2000
  ident: 354_CR1_354
  publication-title: J Leukoc Biol
  doi: 10.1002/jlb.67.4.508
  contributor:
    fullname: A Bowie
– volume: 170
  start-page: 4226
  year: 2003
  ident: 354_CR26_354
  publication-title: J Immunol
  doi: 10.4049/jimmunol.170.8.4226
  contributor:
    fullname: Y Tsutsumi-Ishii
– volume: 12
  start-page: 149
  year: 1990
  ident: 354_CR44_354
  publication-title: Epidemiol Rev
  doi: 10.1093/oxfordjournals.epirev.a036050
  contributor:
    fullname: NM Graham
SSID ssj0017875
Score 2.1332655
Snippet The respiratory epithelium is a major portal of entry for pathogens and employs innate defense mechanisms to prevent colonization and infection. Induced...
Abstract Background The respiratory epithelium is a major portal of entry for pathogens and employs innate defense mechanisms to prevent colonization and...
BACKGROUNDThe respiratory epithelium is a major portal of entry for pathogens and employs innate defense mechanisms to prevent colonization and infection....
BACKGROUND: The respiratory epithelium is a major portal of entry for pathogens and employs innate defense mechanisms to prevent colonization and infection....
Abstract Background The respiratory epithelium is a major portal of entry for pathogens and employs innate defense mechanisms to prevent colonization and...
SourceID doaj
pubmedcentral
biomedcentral
proquest
crossref
pubmed
SourceType Open Website
Open Access Repository
Aggregation Database
Index Database
StartPage 116
SubjectTerms Airway epithelium
beta-Defensins - metabolism
Epithelial Cells - drug effects
Epithelial Cells - metabolism
Human β-defensin 2
Humans
Lipopolysaccharide
Lipopolysaccharides - pharmacology
Lung - drug effects
Lung - metabolism
Pseudomonas
Respiratory Mucosa - drug effects
Respiratory Mucosa - metabolism
Toll-like Receptor 4
Toll-Like Receptor 4 - metabolism
SummonAdditionalLinks – databaseName: DOAJ Directory of Open Access Journals
  dbid: DOA
  link: http://utb.summon.serialssolutions.com/2.0.0/link/0/eLvHCXMwrV1Lb9QwELZQD4gL4k14FB84cLHAr6ktTi1qVSHKAbVSb5HtTMSKVXa1uz30b_FD-E3MJNm24SEuJDfnocTzjTyfPfNZiNcGrC5JtwogO-WKTypEnuYIrbUpB1t6S598huMz9_Hcn9_Y6otzwgZ54KHjyKsBrWmKSegcmjYRxCJgKBqgbctQuqf9lkyN6wcEQz_UFXkVo9GjqI8O8PaqTYHSvM35pNB9Phmfehn_P8Wev6ZQ3hiTju6Ju2MwKfeHn7gvbmH3QNw-GZfLH4rNl-uFdIlLLr-YE94kz9av5Qo5CxjlKUFBzWffkFo4yWWxkk5SLCuJrg_asnLRyn62X_74rhpsOem9k0bmS_lptuRtFi7XqXAB16zBR-Ls6PD0w7Eat1lQ2RGdUQmTJ9JF7pjzu0anlDEWYia6aakht020CanfEUpECN5lNKwql4zNicIh-1jsdIsOnwqJGWzJkUX4i6MjQQoYU-ET6LWVeD_p7Ho5SGrULHI9vUL-xrTE12yqGoipQCXebE1z9WDPYQL8fusBm27y_r6BoFWP0Kr_Ba1KvNoavianY9ukDhcX61rHwEKJ7u93AAEwWO0r8WQAyvUXAw0SRLorsTeB0ORbp1e62dde-FsbIod679n_-Lnn4s5WhVabF2Jns7rAlxRfbfJu70o_AeAoJxA
  priority: 102
  providerName: Directory of Open Access Journals
– databaseName: PubMed Central (Open access)
  dbid: RPM
  link: http://utb.summon.serialssolutions.com/2.0.0/link/0/eLvHCXMwnV1Lb9QwELbaHhAXxJvl6QMHLu7i16wjTlBRVYhFCLVSb5HtTGDVbbLa3R76t_gh_CbGTtISHheSm19yMt_IM_bMZ8ZeKtAyelkLgGCEidYLV6RtDldr7YPTMUt6_gmOTsyHU3u6w-yQC5OD9mNY7DfL8_1m8S3HVq7O43SIE5t-nh9IRUaynE132e5M68FF748OCIG2SymyoiiU7Pl8pIPpVZkAIWW-vQhIY2W6S3aU7r4crVKZzP9vFujvgZS_rEyHt9mt3qTkb7up32E72NxlN-b9ofk9tv1yfZzOcZWSMJaEOp727Dd8jSkWGPkxAUIsF2dIJSnUpV1zw8mi5eS0dwyzvK153vPnP76LCusU-t5wxcMl_7hYpcsWLjc-pjSuRYX32cnh--ODI9FftiCCIadGePSWXC9SyhBeV9L7gEUk_0RWNRWEuiq0x9pbhFggOGsCqsQt55UOnowi_YDtNW2DjxjHADqGIlHxR0OPB--w8DG9QMNO2JvRzy5XHbFGmaiuxzWkdck5sWWSWgnkr8CEvRpEc9UxezIO_mz6LoluNH4uaNdfyx5Q1BdQqyoqj8agok-cEVrRRQlQ15Fm-2IQfEmql2TjG2wvNqUsXKJLNP9uAYRFp6WdsIcdUK5n3ANvwmYjCI3mOq4hbcj03z36H_93zyfs5kBAK9VTtrddX-AzMq224XlWpZ8fxyby
  priority: 500
  providerName: National Library of Medicine
– databaseName: Scholars Portal Journals (Open Access)
  dbid: M48
  link: http://utb.summon.serialssolutions.com/2.0.0/link/0/eLvHCXMwhV1Lj9MwELZgkRAXxJsuLx84cDHgR6aOEEKAWK2QygFtpb1FtjNhK6qkpN0V_ffMpCklSxHJzY4TJ_ONPF9sfyPEcwNWp6ArBRCdcikLyuf8m8NX1obobeosPfkCx1P3-TQ73aUD6j_gci-143xS03b-8ueP9Tty-Ledw3t4Rc6eqTw3WoHSGq6Ka8ZZx3CfuN2UAiEz67V99jS6tN99PhimOjX_fSHo5ZWUfwxNR7fEzT6mlO83ILgtrmB9R1yf9LPmd8XF1918usQF78KYE-wk_7RfyhZ5MTDKE0KEms--I5XwWpemlU5SSCuJtW8kZmVTyS6nn4y4CqrEile_19LIuJbz2YLzLayXIfFOrlmJ98T06NPJx2PV51tQ0RGvUQFDRuyL_DLG16UOIWKeiKLosqKCWJW5DViFDCHlCD5zEQ3LywVjY6C4yN4XB3VT40MhMYJNMWc1_uToCBA85iHxCXTbkXgz-NzFYqOtUbDa9bCGHI_5SVawsQogygIj8WJrnN8NOzLj4e9LP7DxBvfvCpr2W9E7J7UFtKZMJqBzaOgVxwRY9EkDVFWi3j7bmr4g72PrhBqb82Whc8-Kie7fVwDBzludjcSDDVR2PQYaLYh9j8R4AKJBX4c19eysUwDXhliiHh_-96mPxI2t1qw2j8XBqj3HJxRFreLTzjt-AQGIIIg
  priority: 102
  providerName: Scholars Portal
Title Respiratory epithelial cells require Toll-like receptor 4 for induction of human beta-defensin 2 by lipopolysaccharide
URI https://www.ncbi.nlm.nih.gov/pubmed/16219107
https://search.proquest.com/docview/19844754
https://search.proquest.com/docview/68758315
http://dx.doi.org/10.1186/1465-9921-6-116
https://pubmed.ncbi.nlm.nih.gov/PMC1276817
https://doaj.org/article/106e32dc2ae44e2fa57896e8c166ffc9
Volume 6
hasFullText 1
inHoldings 1
isFullTextHit
isPrint
link http://utb.summon.serialssolutions.com/2.0.0/link/0/eLvHCXMwpV1Lj9MwELZgkRAXxJvyKD5w4GKBX1NHnFjEaoUoB7QrrbhEtjMR1VZp1XYP-7f4IfwmZpJ0S8pyIpFy8EuOZ0aeb2x_FuK1Aatz1LUCSE657KMKBYc5Qm1tTMHmVtLTr3B86j6f-bMdWfTeCr4O8JZM2auiMFqB0hpuiluGOc4ZmB9-v1owIL3z3UGirnDP4nNNA3sn2-eDCanl7b_O2dzfM_nHJHR0T9ztvUf5oRP3fXEDmwfi9rRfH38oNt92K-cSl3zeYk4KJjk8v5Yr5G2_KE9I9mo-O0dK4V0ti5V0kpxXSfi8I5OVi1q24X3566eqsOZd7o00Ml3KL7Ml36twuY6ZT2zNKnwkTo8-nXw8Vv29Cio5wi8qYvSEssj-UnpX6RgTFpmgiK5qSkh1VdiIdfQIuUAI3iU0TCMXjU2R_B_7WBw0iwafCokJbE4Fs-5nR0-EGLCImV-gZkfi_WCwy2XHoVEyq_UwhwyMcYgvWVQlEDSBkXizFc1VxRa0BPi76CGLbtB-m0CqVPZGSHUBramyiegcGvrFCSkmhqwB6jpTb19tBV-SlbFsYoOLi3Wpi8DMiO7fJYAUMFjtR-JJpyi7HgPNCoSyR2IyUKFBX4c5zexHy_StDaFBPXn2X6P4XNzZ8s1q80IcbFYX-JI8qU0atxEI-k5dGLf2NG7DXb8BA0Ehtg
link.rule.ids 108,230,315,733,786,790,870,891,2115,2236,24346,24965,27955,27956,53825,53827,76167,76168
linkProvider BioMedCentral
linkToHtml http://utb.summon.serialssolutions.com/2.0.0/link/0/eLvHCXMwpV1Lb9QwELZKkaAXxJvlVR84cDHgR2YdcaKIaoHdPVRbqeIS2c6Erlglq93toX-rP4TfxDiPblPKieTmOJbjmYnns2c-M_ZGgZbByUIAeCNMSJywaVzmsIXWzlsdaklPpjA6Nt9OkpMdNu1yYVbbDeaW7eb03dVE9EX99-6Cxhqbt_Ce7D0RaaqkACEl3GK3CZ5DDPE6OvhxuatAypk02UZN5Zbq54YGrqW_L3qzVk3uf5NHej2w8spMdXif3WtdTP6p6f0DtoPlQ3Zn0m6iP2Kbo-3Xc1zGpIwFaSGPa_hrvsIYG4x8RgoiFvNfSCUx9KVaccPJw-UE4hvGWV4VvN4D4L8vRI5FDIUvueL-nI_ny3j4wvnahZjWNc_xMTs-_DL7PBLt4QvCGwI5wqFLCIqRkXr_IZfOeUwD4RWZF1TgizzVDguXIIQUwSbGo4pcc05p78hJ0k_YblmV-Ixx9KCDTyM1fzB0OXAWUxfiDdTsgH3sDXa2bIg2skh93X9Cwo9gJcmiqDIg_AID9rYTzeWLNbKx8HfVgyi6Xvt1QbX6mbU6Re8CapUH5dAYVPSJQ9JetEECFEWg3u53gs_IFKNsXInV2TqTqY30iebfNYAU0GqZDNjTRlG2PQaaOgiKD9iwp0K9vvaflPPTmg5cKoKMcvj8v0Zxn90dzSbjbPx1-v0F2-sIaqV6yXY3qzN8Ra7Xxr-u7ekPjSoxKg
linkToPdf http://utb.summon.serialssolutions.com/2.0.0/link/0/eLvHCXMwpV1Lb9QwELZKkSouiHeXV33gwMUUPzLriBMFVgXagqpWqrhEtjOmq66yq-z20L_FD-E3MU6y3aaUE8klsh3L8czE82U8Xxh7pUDL4GQUAN4IEzInbJ4-c9iotfNWh0bS-wewe2y-nGQna-zbMhemXgWYO7ab0zdXE9EnzdubLsLZ9qyMrdFb2CaDz0SeKylASAm32G3C55DQ2OHOj8uwAmln1qYbtY07rp8bOriW_z7pLVsNu_9NLun1nZVXlqrRPXa38zH5-1Yp7rM1rB6wjf0uiv6QLQ5Xj89xlrIyJqSGPH3En_Ma0-Zg5EekIWIyPkMqSXtfpjU3nFxcTii-pZzl08ibIAD__UuUGNNe-Ior7i_43niW_r5wMXch5XWNS3zEjkefjj7siu7vC8IbQjnCocsIi5GVev-2lM55zAMBFllGKvCxzLXD6DKEkCPYzHhUiWzOKe0deUn6MVuvphVuMo4edPB54uYPhg4HzmLuQjqBuh2wd73JLmYt00aRuK_7NST9hFayIomqAAIwMGCvl6K5vLGBNhb-brqTRNfrvymY1j-LzlTpXkCtyqAcGoOKHnFI6os2SIAYA412ayn4gmwxycZVOD2fFzK3iT_R_LsFkAJaLbMBe9IqymrEQGsHYfEBG_ZUqDfWfk01Pm34wKUizCiHT_9rFrfYxvePo2Lv88HXZ-zOkqBWqudsfVGf4wtyvRb-ZWNOfwD_EjD1
openUrl ctx_ver=Z39.88-2004&ctx_enc=info%3Aofi%2Fenc%3AUTF-8&rfr_id=info%3Asid%2Fsummon.serialssolutions.com&rft_val_fmt=info%3Aofi%2Ffmt%3Akev%3Amtx%3Ajournal&rft.genre=article&rft.atitle=Respiratory+epithelial+cells+require+Toll-like+receptor+4+for+induction+of+human+beta-defensin+2+by+lipopolysaccharide&rft.jtitle=Respiratory+research&rft.au=MacRedmond%2C+Ruth&rft.au=Greene%2C+Catherine&rft.au=Taggart%2C+Clifford+C&rft.au=McElvaney%2C+Noel&rft.date=2005-10-12&rft.eissn=1465-993X&rft.volume=6&rft.spage=116&rft.epage=116&rft_id=info:doi/10.1186%2F1465-9921-6-116&rft.externalDBID=NO_FULL_TEXT
thumbnail_l http://covers-cdn.summon.serialssolutions.com/index.aspx?isbn=/lc.gif&issn=1465-993X&client=summon
thumbnail_m http://covers-cdn.summon.serialssolutions.com/index.aspx?isbn=/mc.gif&issn=1465-993X&client=summon
thumbnail_s http://covers-cdn.summon.serialssolutions.com/index.aspx?isbn=/sc.gif&issn=1465-993X&client=summon